OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
115
Results
Show all
Save search
Copy query
Show results for
Unknown
(115)
Publication Date
Release Date
2021
(18)
2024
(14)
2022
(14)
2023
(12)
2025
(10)
2015
(6)
2020
(5)
2018
(5)
2013
(5)
2012
(5)
2016
(4)
2009
(4)
2014
(3)
2011
(3)
2026
(2)
2019
(2)
2017
(2)
2010
(1)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Not available
S-EPMC4451172
|
biostudies-literature
Cite
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC11618571
|
biostudies-literature
Cite
A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.
Not available
S-EPMC7321835
|
biostudies-literature
Cite
Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial.
Not available
S-EPMC3177753
|
biostudies-literature
Cite
The long-term effectiveness of a lifestyle intervention in severely obese individuals.
Not available
S-EPMC3574274
|
biostudies-literature
Cite
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
Not available
S-EPMC3270008
|
biostudies-literature
Cite
Biomarker clustering in autosomal dominant Alzheimer's disease.
Not available
S-EPMC9525451
|
biostudies-literature
Cite
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
Not available
S-EPMC8026051
|
biostudies-literature
Cite
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Not available
S-EPMC9828339
|
biostudies-literature
Cite
Modeling autosomal dominant Alzheimer's disease with machine learning.
Not available
S-EPMC8195816
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets